ETFIQData as of Nov 19, 2026. · etfiq.com/funds/adpv

ADPV Fact Sheet: Adaptiv Select ETF

Share
$40.55
close, Nov 20, 2026

Over the year to Nov 19, 2026, ADPV returned +1.4% in total and charged 1.00% a year.

1-year total return
+4.5%
to Nov 20, 2026
Expense ratio
1.00%
a year

Growth of $10,000, 1 year

ADPV $10,142 +1.4% · Total return, distributions reinvested, Nov 19, 2025 to Nov 19, 2026.

Returns

WindowTotal return
1 month−8.3%
3 months−10.2%
Year to date−5.3%
1 year+4.5%
3 years+76.0%

Total return, distributions reinvested, each window to Nov 20, 2026.

Ten largest positions

HoldingWeight
Intel Corp5.26%
Arrowhead Pharmaceuticals Inc4.99%
Hewlett Packard Enterprise Co4.92%
Viatris Inc4.75%
Viavi Solutions Inc4.39%
Roivant Sciences Ltd4.38%
Host Hotels & Resorts Inc4.36%
Healthcare Realty Trust Inc4.34%
Millicom International Cellula4.19%
Terawulf Inc4.13%

ADPV top ten by weight, 45.7% of the fund, of its 26 equity positions, from the holdings filed for Jul 31, 2026.

Facts

Equity fund · Actively managed · First traded Nov 4, 2022 · Benchmark Its own holdings, as of Jul 31, 2026; its prospectus names no index it tracks

Source: ETFIQ, from issuer disclosures, SEC filings and exchange prices. Returns from daily closes, distributions reinvested; each number is dated beside it, and every one is on the fund’s page.Cite as: ETFIQ, ADPV Fact Sheet: Adaptiv Select ETF. Data as of Nov 19, 2026. https://etfiq.com/funds/adpv/fact-sheet/ETFIQ is an independent publisher. Not an issuer, broker or adviser. No recommendations. Printed from etfiq.com/funds/adpv.